ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,530Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 32

$486K Total Retail Price of All Prescriptions

Rank: 5 out of 32

505 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 6,376 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 455 362 1 2
HYDROCODONE-ACETAMINOPHEN 334 218 S3 2 1
PRAVASTATIN SODIUM 303 256 3 10
METOPROLOL TARTRATE 258 156 4 7
OMEPRAZOLE 252 140 5 8
METFORMIN HCL ER 236 150 6 36
HYDROCHLOROTHIAZIDE 214 151 7 11
LISINOPRIL 201 162 8 3
FUROSEMIDE 200 165 9 5
LEVOTHYROXINE SODIUM 165 104 10 4
ISOSORBIDE MONONITRATE ER 164 116 11 49
POTASSIUM CHLORIDE 155 106 12 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 153 107 13 19
RANITIDINE HCL 142 98 14 12
ATORVASTATIN CALCIUM 137 83 15 15
SERTRALINE HCL 131 58 16 24
WARFARIN SODIUM 124 100 17 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 124 75 17 41
GABAPENTIN 116 65 19 16
CLONIDINE HCL 116 98 19 31
MELOXICAM 110 60 21 33
ALLOPURINOL 108 73 22 26
TRAZODONE HCL 104 69 23 53
ACTOS 101 55 24 67
GLYBURIDE 96 63 R 25 142
DONEPEZIL HCL 93 84 26 30
METOPROLOL SUCCINATE 89 77 27 18
FAMOTIDINE 85 56 28 47
LANTUS 84 53 29 29
NEXIUM 84 47 29 23
SIMVASTATIN 80 74 31 6
ATENOLOL 80 68 31 17
LOSARTAN POTASSIUM 78 64 33 37
VENTOLIN HFA 77 63 34 65
TRAMADOL HCL 76 53 35 13
CRESTOR 74 48 36 21
PROAIR HFA 73 11 37 77
METFORMIN HCL 73 45 37 9
QUETIAPINE FUMARATE 67 43 39 51
AMITRIPTYLINE HCL 62 50 R 40 90
ZOLPIDEM TARTRATE 60 16 41 20
RISPERIDONE 56 23 42 39
DIOVAN 55 47 43 42
LOSARTAN-HYDROCHLOROTHIAZIDE 52 40 44 45
NIFEDIPINE ER 51 31 45 99
INSULIN SYRINGE 51 46 45 75
MIRTAZAPINE 50 25 47 50
PIOGLITAZONE HCL 50 26 R 47 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.